Upstate Active Clinical Trials

Study Title:

Bayer Protocol 13024: A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of on-demand and prophylactic treatment with BAY 94-9027 in Severe Hemophilia A

Upstate Institutional Review Board (IRB) Number:

357407

Study Phase:

II, III

Patient Age Group:

Adults

Principal Investigator:

Thomas E Coyle, MD

ClinicalTrials.Gov ID:

NCT01580293

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Diane M Gould
Phone: 315-464-8235
Email: gouldd@upstate.edu

Return to Previous Page || Search Again